As SIRT6 falls with age, APP rises. A SIRT6 activator reduced plaque burden in mice. The AD connection? SIRT6 deacetylates three adjacent lysines in amyloid precursor protein, and this ...
The funding will be used to accelerate the development of the company’s technology that analyzes proteins and their post-translational modifications to predict the treatment responses of patients with ...
Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment. This ...